Clinical Trials Directory

Trials / Completed

CompletedNCT00000275

Cocaine Abuse and ADHD - 10

Cocaine Abuse and ADHD

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
16 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of buproprion in treating individuals with adult attention-deficit hyperactivity disorder (ADHD) and cocaine dependence.

Conditions

Interventions

TypeNameDescription
DRUGFlupenthixol

Timeline

Start date
1996-11-01
Completion
1998-03-01
First posted
1999-09-21
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000275. Inclusion in this directory is not an endorsement.

Cocaine Abuse and ADHD - 10 (NCT00000275) · Clinical Trials Directory